Centrum Zdrowia I Urody Maxxmed
- Address
- Ul. Niecala 15, 20-080 Lublin, Poland
Neurological Disorders Research
At Centrum Zdrowia I Urody Maxxmed the focus is on neurodegenerative conditions such as Parkinson's disease and agitation associated with Alzheimer's disease, aiming to test new therapies that improve motor function and behavioral symptoms.
- Evaluation of novel agents for tremor reduction
- Assessment of treatments to decrease OFF time
- Investigation of therapies to extend ON time
- Study of medications targeting agitation in dementia
The program involves three investigators across six clinical studies, providing patients with access to innovative approaches that may enhance daily living and safety.
Dermatology & Skin Health Studies
Researchers at the Lublin clinic are addressing atopic dermatitis, a chronic inflammatory skin condition, by evaluating long‑term safety and effectiveness of emerging biologic treatments, with the goal of reducing symptoms and improving quality of life.
- Long‑term safety monitoring of biologic therapy
- Assessment of symptom relief and skin barrier improvement
- Exploration of treatment options for moderate‑to‑severe disease
- Evaluation of patient‑reported outcomes in chronic dermatitis
This work complements the neurological portfolio, reflecting the site’s commitment to diverse therapeutic areas and patient‑centered care.
Site Overview
Activity Indicator
Last 6 months
Trial Flow
How this site's trials are distributed across therapeutic areas and active substances (IMPs), and how they're positioned within their overall lifecycle status. Flow thickness represents the number of unique trials.
Compounds & Molecules Timeline
The time span of clinical-trial activity for the main active substances (IMPs) studied at this site over the last 8 years. Each bar runs from the earliest trial start to the most recent end; a substance with a trial still open has no recorded end and is shown as ongoing.
Sponsor & Partnership
Top sponsors by active trials, and the ones that have come back for more than one study.
Sponsor Network
Top 10 by active trials.
No sponsors linked to active trials.
Partnership History
Sponsors with repeated collaboration (≥ 2 trials).
- 1Amgen Inc.2trials
Sponsor Network Graph
How sponsors and therapeutic areas connect across this site's active trials: each link is at least one active trial shared between them, and bigger nodes mean more activity. Click a node to see its exact connections.
Country Benchmark
Compared to 1 624 other sites in Poland
Therapeutic Area Benchmark — Poland
Select a therapeutic area to compare against other sites in Poland.
Competitor Comparison
Similar sites in the same country running a comparable number of trials (within ±30%), scored on how closely their trial portfolios match this one. Higher percentages mean a more similar profile.
Country: Poland
Market Share
Country: Poland
Therapeutic Area Market Share
Select a therapeutic area to view its disease coverage breakdown.
Heat Maps & Advanced Analytics
How often specific conditions appear in trials across this site and comparable sites from the same country. Each row is a site, each column a condition, and each cell the number of trials on it — darker means more activity.
Other Trials in Centrum Zdrowia I Urody Maxxmed
lock Showing 1 of 7 trials — the rest is available on a paid plan.
| Trial | Sponsor | Phase | Status | Start Date | End Date |
|---|---|---|---|---|---|
| A Phase 3, 24-week, Randomized, Placebo-controlled, Double-blind Study to Assess the Efficacy, Safety and Tolerability of Rocatinlimab (AMG 451) Monotherapy in Adult Subjects With Moderate-to-severe Atopic Dermatitis (AD) (ROCKET-Ignite) | Amgen Inc. | Phase III | Not Recruiting | Apr 2023 | Sep 2024 |
IMP list
lock Showing 1 of 8 compounds — the rest is available on a paid plan.
| IMP | Trials | Status | First start | Last start |
|---|---|---|---|---|
| Rocatinlimab | 2 | Unknown | 2023-04-25 | 2023-10-20 |
Request feasibility information
Ask this centre about capacity, equipment and patient population.
Upgrade this site to Business Plan
Own the profile, publish your feasibility data and reach sponsors directly.
Is something out of date?
Tell us what needs correcting and we'll update this profile.
lock Available to Business plan sites only.